InvestorsHub Logo
Followers 58
Posts 10109
Boards Moderated 1
Alias Born 09/21/2016

Re: AceT post# 301174

Monday, 03/01/2021 12:30:27 PM

Monday, March 01, 2021 12:30:27 PM

Post# of 460562
AceT:

One example CM mentioned was that during the Rett planning the discussions provided insight on how tough the mobility can be for that community so they designed the trial to allow for more in home visits, blood draws for example, that would limit the travel needs. This proved to be very beneficial during Covid.

Nadia - Advocacy groups and community ecosystem groups can provide different insights and recommended to interact with both during the planning phases.

CM - We have found that making the patient the focus instead of the compound the focus allows us to design better trials for all.



Great catch. I am very hopeful that this kind of science/human interface mix was also allowed in the practice of PDD Actigraphy data gathering methods and practices.

I remain grateful that Dr.M. and AVXL team have remained focused and insightful of , "just why are we doing this", as they plan and execute clinical trials.

Paying close attention to trial execution context (w/trial subjects) can help to avoid misunderstandings and errors in interpretation.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News